Literature DB >> 20108376

Incidence of Parkinson's disease and parkinsonism in northern Sweden: a population-based study.

Jan Linder1, Hans Stenlund, Lars Forsgren.   

Abstract

The differential diagnosis of parkinsonian disorders is difficult, especially early in the course of the diseases. The clinical subtypes of Parkinson's disease (PD) have not so far been described in newly diagnosed patients. We present a prospective incidence cohort study of patients with idiopathic parkinsonian syndromes in the Umeå region in northern Sweden identified over a 4-year period. The clinical diagnoses were re-evaluated at follow-up visits at 12 months. We found 138 patients with parkinsonism: 112 PD, 12 multiple system atrophy with predominant parkinsonism (MSA-P), six progressive supranuclear palsy (PSP) and eight unclassifiable patients. The crude incidences for all age ranges per 100,000 were: PD 19.7 (95% confidence interval 16.1-23.3); MSA-P 2.1 (1.1-3.7); PSP 1.1 (0.4-2.4); idiopathic parkinsonism 24.3 (20.2-28.4). Age-standardized to the average Swedish population 2004-2007: PD 22.5 (18.3-26.7); MSA-P 2.4 (1.2-4.2); PSP 1.2 (0.4-2.6); idiopathic parkinsonism 27.5 (22.9-32.1). The crude annual incidence rate for PD, with exclusion of patients with normal dopamine receptor uptake (FP-CIT-SPECT), was 18.8 per 100,000 (95% confidence interval 15.2-22.4), age-adjusted to the average Swedish population 2004 to 2007: 21.5 (17.4-25.6). The incidence rates did not differ significantly between men and women. The cumulative incidence of PD up to 89 years of age was for men 3.4%, for women 2.6%, and for both sexes combined 2.9%. The annual incidence rates found for PD, idiopathic parkinsonism, MSA-P and PSP are among the highest reported. (c) 2010 Movement Disorder Society.

Entities:  

Mesh:

Year:  2010        PMID: 20108376     DOI: 10.1002/mds.22987

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  42 in total

1.  Olfactory Function, Eating Ability, and Visceral Obesity Associated with MMSE Three Years after Parkinson's Disease Diagnosis.

Authors:  M Vikdahl; M E Domellöf; L Forsgren; L Håglin
Journal:  J Nutr Health Aging       Date:  2015-11       Impact factor: 4.075

2.  Persistence of associations between cognitive impairment and motor dysfunction in the early phase of Parkinson's disease.

Authors:  Magdalena E Domellöf; Lars Forsgren; Eva Elgh
Journal:  J Neurol       Date:  2013-05-29       Impact factor: 4.849

Review 3.  Epidemiology of Parkinson's disease.

Authors:  Ole-Bjørn Tysnes; Anette Storstein
Journal:  J Neural Transm (Vienna)       Date:  2017-02-01       Impact factor: 3.575

Review 4.  A systematic review of loss of independence in Parkinson's disease.

Authors:  Angus D Macleod; J W Kerr Grieve; Carl E Counsell
Journal:  J Neurol       Date:  2015-07-15       Impact factor: 4.849

Review 5.  Genetic predispositions of Parkinson's disease revealed in patient-derived brain cells.

Authors:  Jenne Tran; Helena Anastacio; Cedric Bardy
Journal:  NPJ Parkinsons Dis       Date:  2020-04-24

6.  Neuroprotection by marine-derived compound, 11-dehydrosinulariolide, in an in vitro Parkinson's model: a promising candidate for the treatment of Parkinson's disease.

Authors:  Wu-Fu Chen; Chiranjib Chakraborty; Chun-Sung Sung; Chien-Wei Feng; Yen-Hsuan Jean; Yen-You Lin; Han-Chun Hung; Tzu-Yi Huang; Shi-Ying Huang; Thung-Ming Su; Ping-Jyun Sung; Jyh-Horng Sheu; Zhi-Hong Wen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-11-27       Impact factor: 3.000

7.  Intake of vitamin B before onset of Parkinson's disease and atypical parkinsonism and olfactory function at the time of diagnosis.

Authors:  L Håglin; I Johansson; L Forsgren; L Bäckman
Journal:  Eur J Clin Nutr       Date:  2016-10-05       Impact factor: 4.016

8.  Incidence and Trends of Progressive Supranuclear Palsy and Corticobasal Syndrome: A Population-Based Study.

Authors:  Cole D Stang; Pierpaolo Turcano; Michelle M Mielke; Keith A Josephs; James H Bower; J Eric Ahlskog; Bradley F Boeve; Peter R Martin; Sudhindra G Upadhyaya; Rodolfo Savica
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

9.  The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher Registry.

Authors:  Barry Rosenbloom; Manisha Balwani; Jeff M Bronstein; Edwin Kolodny; Swati Sathe; Andrea R Gwosdow; John S Taylor; J Alexander Cole; Ari Zimran; Neal J Weinreb
Journal:  Blood Cells Mol Dis       Date:  2010-11-10       Impact factor: 3.039

10.  Impaired oculomotor function in a community-based patient population with newly diagnosed idiopathic parkinsonism.

Authors:  Jan Linder; Britt-Inger Wenngren; Hans Stenlund; Lars Forsgren
Journal:  J Neurol       Date:  2011-12-16       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.